Condition
Menopause Hot Flashes
Total Trials
5
Recruiting
2
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 5/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
40%
2 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (1)
P 2 (2)
P 3 (1)
P 4 (1)
Trial Status
Recruiting2
Not Yet Recruiting2
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06975111Phase 2Recruiting
Focusing on the Menopausal Transition to Improve Mid-Life Women's Health
NCT07218445Phase 4Recruiting
The Effect of Tirzepatide on Menopausal Vasomotor Symptoms and Biological Aging in Post-menopausal Women With Obesity
NCT07606664Phase 3Not Yet RecruitingPrimary
Fezolinetant and Vascular Health and Brain Health
NCT07375732Not ApplicableNot Yet Recruiting
Transcranial Electrical Stimulation for Noninvasive Study of Menopausal/Perimenopausal Symptoms
NCT03291067Phase 2CompletedPrimary
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Showing all 5 trials